NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beijing Safe Pharmaceutical Technology Co., Ltd.

Beijing Safe Pharmaceutical Technology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.safeglp.com/

Last Round

IPO

Feb 26, 2021

Est. Valuation

$6.5B

Company Overview

Beijing Safe Pharmaceutical Technology Co., Ltd. is a biotechnology company that provides preclinical safety assessment, toxicology services, and drug development support for biopharmaceutical and medical device companies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Application

Keywords

contract research organizationCROpreclinical drug developmentdrug discovery servicesGLP-compliantbiotech outsourcingtoxicology servicesIND-enabling studiesDMPKdrug metabolism and pharmacokineticsregulatory consultingNHPnon-human primate breedingantibody drug discoveryorganoid-based screeningradiopharmaceutical developmentlab animal supply

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Safe Pharmaceutical Technology Co., Ltd. Comparables

Compare Beijing Safe Pharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Safe Pharmaceutical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Joinn Laboratories (China) Co., Ltd.
91%
Shanghai InnoStar Bio-tech Co., Ltd.
88%
Frontage Holdings Corporation
86%

Beijing Safe Pharmaceutical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOFeb 26, 2021
IPOAug 25, 2017

Beijing Safe Pharmaceutical Technology Co., Ltd. Investors

Notable investors and investment history

Beijing Safe Pharmaceutical Technology Co., Ltd. investors
InvestorRounds
CLSAIPO
Lake Bleu CapitalIPO
招银国际金融有限公司IPO
The Valliance FundIPO
China International Capital CorporationIPO
OrbiMedIPO
Sequoia CapitalIPO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2017

    $38M IPO round completed.

Beijing Safe Pharmaceutical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Safe Pharmaceutical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about Beijing Safe Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range11
Year Founded2016
Last FundingFeb 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.